The TARGIT trial is run by the Clinical Trials Group of
the Department of Surgery, University College London. This experienced
centre co-ordinates large multi-centre phase III randomised breast
cancer clinical trials. Joan Houghton has over 30
years experience in clinical trials and heads up the international
TARGIT team in London. Norman Williams is the TARGIT
Clinical Project
Manager and co-ordinates the daily trial activities. Dr Ingrid Potyka is responsible for the
trial’s IT requirements. Tammy Corica co-ordinates TARGIT in Australasia and is
also a member of the ISC. Max Bulsara, University
of Western Australia, is the trial’s statistician and is also be a
member of the Data Monitoring Committee
We are
based in the Department of Surgery at University College, London and
some of the staff have been involved in major cancer trials in breast
(and other sites) for more than 20 years. We were one of the first
groups to evaluate the role of radiotherapy following mastectomy in the
1970s, subsequently showing the detriment to long-time survivors with
left sided tumours that has now been confirmed by the Oxford overview.
We further evaluated the role of radiotherapy in patients who had local
excision but were also treated with tamoxifen. We have also been very
active in the endocrine management of early disease—initially with
tamoxifen but now continuing with an important role in the ATAC and ZIPP
trials.
Any enquiries about the trial should be addressed to the International Steering Committee at the TARGIT
Trial Operations Office
International
TARGIT Trial
Clinical Trials Group
Department of Surgery
Royal Free and UCL Medical School
Centre for Clinical Science and Technology
Clerkenwell Building, Archway Campus
Highgate Hill
London N19 5LW
Tel
+44 (0) 20 7288 3970
Fax
+44 (0) 20 7288 3969
Email general enquiries to TARGIT.
Note: Remove the "noreply" before sending.
Page last modified: 20 Mar 2006